The mechanisms of action of antiepileptic drugs effective against generalized absence seizures (antiabsence AEDs) remain uncertain. Antiabsence AEDs are generally effective against seizures induced in experimental animals by pentylenetetrazol (PTZ) and methyl~,7-dimethoxy~-ethyl-~-carboline-3-c~boxy~ate (DMCM), drugs which reduce GABAergic inhibition. Thus, antiabsence AEDs have been suggested to enhance GABAergic inhibition. We studied the effects of several AEDs on GABA responses recorded from mouse spinal cord neurons grown in primary dissociated cell culture. Four antiabsence AEDs were included: ethosuximide (ESM), dimethadione (DMO), sodium valproate (VPA), and diazepam (DZP). Two experimental AEDs, CGS 98% and ZK 912%, with anticonvulsant action against PTZ-or DMCM-induced seizures were also included. Possible effects of the antiabsence and experimental AEDS on PTZ-and DMCM-induced inhibition of GABA responses were also evaluated. PTZ and DMCM reversibly reduced GABA responses in a concentrationdependent manner. PTZ completely inhibited GABA responses at 10 mM (ICso of 1.1 mM), whereas DMCMinduced inhibition of GABA responses reached a plateau level of 39% of control values at 1 p M (ICso of 33 nM). ESM (1,200 p m , DMO (6 mM), VPA (200 pM), CGS 98% (2 pM), and ZK 98% (2 pM) did not alter GABA responses. DZP enhanced GABA responses in a concentration-dependent manner. The inhibition of GABA responses produced by PTZ 1 mM was unaltered by ESM (600 pi' @), DMO (6 mM), CGS 98% (1 pkf), or ZK 98% (1 pM). Coapplication of VPA (200 pM) and PTZ (1 mM) slightly enhanced the FTZ effect. DZP (>lo nM), however, reversed the PTZ-induced reduction of GABA responses. The DMCM (250 nM) inhibition of GABAresponses was unaltered by ESM (600 pw, DMO (2 mM), or VPA (200 pM). CGS 98% (2 pM) and ZK 912% (2 pM), however, antagonized the DMCM effect. DZP (> 10 nM) significantly reversed the DMCM-induced inhibition of GABA responses. The lack of effect of VPA, ESM, and DMO on postsynaptic GABA responses suggests that direct enhancement of postsynaptic GABA action is not a common mechanism of action of antiabsence AEDs. The AEDs DZP, CGS 9896, and ZK 912% all reversed DMCM, but not PTZ, reduction of GABA responses, suggesting that these AEDs blocked DMCM seizures by acting at benzodiazepine receptors. However, since only DZP enhanced GABA responses, it is unclear how CGS 98% and ZK 912% blocked PTZ seizures.
alized absence seizures (antiabsence AEDs) may involve enhancement of GABAergic inhibition .
The GABAA receptor is an oligomeric complex containing binding sites for GABA, barbiturates, benzodiazepines, f3-carbolines and picrotoxinlike drugs (Olsen, 1981;  Olsen and Leeb-Lundberg, 1981) . The structure of the GABA, receptor was recently deduced from cDNA clones and is composed of two a and two f3 peptide subunits which span the neuronal membrane to form a chloride channel (Schofield et al., 1987) . GABA binds to the 17
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receptor to open the chloride channel, resulting in membrane hyperpolarization and inhibition.
Several convulsants, including bicuculline, picrotoxin, penicillin, D-tubocurarine, pentylenetetrazol (PTZ) and a-keto-6-guanidino-valeric acid have been shown to be GABA antagonists, blocking the inhibitory action of GABA by interacting with either GABA or picrotoxin binding sites (Curtis et al., 1971; Curtis et al., 1972; Hill et al., 1972; Hill and Simmonds, 1973; Macdonald and Barker, 1978~; Johnston and Willow 1981; Olsen and LeebLundberg, 1981; De Deyn et al., 1988) . Benzodiazepine receptor ligands which were convulsant or proconvulsant, such as the P-carbolines PCCM, PCCE, and DMCM and the pyrazoloquinoline CGS 82 16 reduced GABAergic inhibition through an allosteric interaction with the GABAA receptor (Braestrup et al., 1983; Peterson, 1983) .
AED reduction of seizures induced in experimental animals by either intravenous (i.v.) or subcutaneous (s.c.) administration of PTZ has been used to predict antiabsence efficacy of drugs such as diazepam (DZP), trimethadione (TMO), sodium valproate (VPA), and ethosuximide (ESM) (Swinyard, 1969) . The antiabsence AEDs were also effective against DMCM-induced seizures (Petersen, 1983) . Experimental drugs also have an anticonvulsant action in experimental animals against PTZ or DMCM seizures. The pyrazoloquinoline, CGS 9896, was anticonvulsant in the PTZ test (Petrack et al., 1983) , and the p-carboline, ZK 91296, was protective against PTZ-and DMCM-induced seizures (Petersen et al., 1984; Klockgether et al., 1985) . Enhancement of GABA-mediated inhibition has been proposed as the mechanism of action of several AEDs used extensively in human therapy (Eccles et al., 1963; Nicoll, 1972; Macdonald and Barker, 19786, 1979; Gent and Phillips, 1980; Shultz and Macdonald, 1981) . Anticonvulsant benzodiazepines such as DZP directly enhance GABA responses (Choi et al., 1977; Macdonald and Barker, 19786) , whereas VPA increases brain and synaptosoma1 GABA concentration (Godin et al., 1969; Simler et al., 1973; Iadarola and Gale, 1979) . However, although DZP has been shown to enhance GABA responses, no clear action of TMO [or its active metabolite, dimethadione (DMO)] VPA, or ESM on GABAergic inhibition at clinically relevant concentrations has been reported.
In this study, we determined whether or not the antiabsence (ESM, DMO, VPA, and DZP) and two experimental (CGS 9896 and ZK 91296) AEDs had an action on postsynaptic GABA responses on mouse spinal cord neurons grown in primary dissociated cell culture at clinically re'cvant concentrations. We also determined the concentrationdependent effects of the convulsant drugs PTZ and DMCM on GABA responses and the effects of the AEDS on PTZ-and DMCM-induced reduction of GABA responses.
MATERIALS AND METHODS

Primary dissociated cell culture
Cultures of spinal cord neurons were prepared from dissected spinal cords and attached dorsal root ganglia from 12-14-day-old fetal mice as described previously (Ransom et al., 1977) . Experiments conformed to the policy of the American Physiological Society. The tissue was minced and then mechanically dissociated by trituration in Ca2+-and M$+-free balanced salt solution to a suspension of single cells and small clumps. The dissociated cells were suspended in culture medium [W% Eagle's miminal essential medium (MEM) supplemented with 5.5 g glucose and 1.5 g NaHCO,/L, 5% heatinactivated horse serum, and 5% Nu-Serum I1 (Collaborative Research) 325 mOsm] and then plated on sterile collagen-coated 35-mm dishes. The cultures were maintained in an incubator with an atmosphere of 93% room air and 7% CO, at 35°C. The bicarbonate/CO, buffer maintained pH at 7.4. 5-Fluoro-2'deoxyuridine was added to the cultures on days 4-6 to suppress the growth of rapidly dividing non-neuronal cells. Medium was changed twice weekly. Cultures were maintained for 4-9 weeks before electrophysiologic experiments were made.
Experimental procedures
Solutions
All recordings were made in a high magnesium ion concentration of Dulbecco's phosphatebuffered saline (PBS) after removal of growth medium. The elevated magnesium ion concentration in the recording solution suppressed spontaneous synaptic and action potentials. The recording solution contained (in mM): NaCl 137, Na2HP04, 8.06, KCl 2.68, KH2P04 1.47, CaCl, 1, MgCI, 10, and glucose 5.6 (pH 7.4). Heavy paraffin oil was applied to the surface of the bathing solution to retard evaporation.
Solutions of drugs were always prepared on the day of the experiment in the following manner: DMCM, DZP, and VPA were dissolved in dimethylsulfoxide (DMSO) to form lo-, 1-, and 60-mM stocks, respectively. DMO, ESM, and PTZ were dissolved in recording solution to form 12-, 6-, and 10-mM stocks, respectively. Aliquots were removed and diluted in bathing medium to obtain the Epilepsia, Vof. 30, No. 1 , 1989 applied concentrations. The final solutions contained GO. 1% DMSO.
DMCM was applied at concentrations between 1 nM and 10 p M . PTZ concentrations ranged between 62.5 p M and 10 mM. In the experiments testing the effects of AEDs on DMCM-and PTZinduced reduction of GABA responses, DMCM was used at a concentration of 250 nM and PTZ was used at a concentration of 1 mM. The ranges of AED concentrations tested were determined from human clinical pharmacologic data when available. Concentrations equivalent to the clinically useful therapeutic range in CSF or comparable to the free levels in serum were used (Gugler et al., 1977; Eadie and Tyrer, 1980; Sherwin, 1982; Wilder and Karas, 1982) .
Experimental apparatus
For experiments, the culture dish containing bathing solution was placed on a microscope stage heated by a Pellitier device with temperature regulated at 3435°C. The stage was mounted on a Leitz inverted microscope fitted with phase-contrast optics to facilitate micropipette placement (using Leitz micromanipulators) and to penetrate cells under direct visual control.
Electrophysiologic recordings
Intracellular recordings were made from the somata of spinal cord (>20 pm) neurons using glass micropipettes (25-50 Ma) filled with 3M KCI. Use of an active bridge circuit (Model 8100, Dagan, Minneapolis, MN, U.S.A.) allowed simultaneous recording of membrane potential and injection of current (for steady-state polarization or periodic stimulation) using a single micropipette. The preamplifier output signal was led to a six-channel polygraph (Model 2600, Gould Instruments, Cleveland, OH, U.S.A.) for continuous recording.
GABA responses
GABA (0.5 M, pH 3.4) was applied iontophoretically using 500-ms duration rectangular current pulses at 5-s intervals. Tips of iontophoretic pipettes were positioned to within 2 pm of neuronal somata. The use of 3M KC1-filled micropipettes resulted in elevation of intracellular chloride ion concentration and a shift in the chloride equilibrium potential from about -65 mV to about -20 mV. Under these conditions, an increase in chloride conductance resulted in an outward chloride current giving depolarizing GABA responses (Nowak et al., 1982) . Responses of -10-15 mV in amplitude were evoked following membrane hyperpolarization (to between -70 and -90 mV) to avoid saturation at or near the chloride equilibrium potential.
Direct effects of convulsant drugs and AEDs on GABA responses were accepted only if the GABA responses returned to control amplitude within 5-10 min of removal of the drug-containing micropipette. In the studies evaluating effects of coapplication of the AEDs and the convulsant drugs on GABA responses, data were accepted only when the original direct effect of the convulsant drug could again be evoked after recovery of the GABA response from the combination effect.
Drug application
For evaluation of drug effects on GABA responses, all drugs were applied by a perfusion micropipette. A blunt-tipped (10-15 pm) micropipette, filed with the recording solution containing convulsant or convulsant and AED, was positioned 15-30 pm from the soma of the cell under study. The open end of the perfusion micropipette was connected to a pressure regulator, set between 0.4 and 0.8 psi, by tight-fitting polyethylene tubing. Pressure-pulse duration, regulated by a voltage-activated three-way valve, was 10 s. Under these conditions, local perfusion produced no artifacts, and application of recording solution (with or without vehicle) was virtually free of effects. When the effect of coapplication of convulsant drugs and AEDS was studied, the drugs were applied through one perfusion micropipette to avoid flow artifacts. The concentrations reported in this study are those contained in the perfusion micropipettes. Although some reduction in the concentration of drug at the neuron may have occurred due to dilution in the surrounding medium, increasing durations of application or altering the position of the perfusion micropipette did not increase the effects of the drugs. Thus, although there may be some small inaccuracy in the drug concentrations, the reported concentrations are probably close to those at the surface of the neuron.
The perfusion micropipettes and recording micropipettes were held by Leitz micromanipulators. To decrease leakage of drugs into the bathing medium, the tips of the perfusion micropipettes were kept in the oil phase between drug application trials. They were lowered in the aqueous phase only when drug application was desired. 
Algebraic and statistical methods
Mean values and SD were calculated for GABA response amplitudes before, during, and after drug application. Mean values and SD for the effects of the coapplied convulsant drugs and AEDs on GABA responses were also calculated.
All effects were expressed as percentage of change in GABA response from control GABA response. The statistical significance of differences between GABA responses with and without drug application was calculated using the two-tailed Student's t test; p < 0.05 was considered statistically significant.
RESULTS
Direct effects of convulsant drugs PTZ and DMCM on GABA responses
Application of PTZ or DMCM to spinal cord neurons did not alter resting membrane potential or conductance. Application of recording solution (with or without vehicle) (n = 10) did not significantly alter GABA responses (100.8 k 1.9%).
PTZ and DMCM rapidly and reversibly reduced GABA responses. The PTZ effect was concentration-dependent (Fig. 1) . A si&icant 6.2 -+ 2.1% decrease of GABA responses (p < 0.001) was obtained at 125 ptf, and complete inhibition was obtained at 10 mM. The DMCM effect was also concentration dependent (Fig. 2) 
Effects of AEDs on FTZ-induced antagonism of
GABA responses
The reduction of GABA responses produced by PTZ (1 mM) was unaltered by ESM (600 pM) and DMO (2 and 6 mM) ( Table 2) . Similarly, the benzodiazepine receptor antagonists, CGS 9896 (1 pV) and ZK 91296 (1 phi), did not alter PTZ (1 mM) reduction of GABA responses Vable 2 and Fig. 4A (Table 3) . Coapplication of DZP, CGS 9896 or ZK 91296, however, influenced the DMCM-induced inhibition of GABA-responses (Table 3) . CGS 9896 (2 p M ) and ZK 91296 (2 CLM) significantly antagonized the DMCM-induced inhibition of GABA responses (Table 3 and Fig. 4C and D). DZP, with a threshold concentration of 10 nM (p < 0.05), significantly reversed the DMCMinduced inhibition of GABA responses (Fig. 3B ). Simultaneous application of DMCM 250 nM and DZP 500 nM resulted in a small increase (5.5%) in GABA responses compared to control responses (Table 3) . To understand the mechanism(s) of action of antiabsence AEDs better, we investigated the effects of some clinically and/or experimentally proven AEDs on GABA responses recorded from mouse spinal cord neurons in cell culture. The effects of two convulsant drugs used in chemical animal models of epilepsy, PTZ and DMCM, were studied as well. Furthermore, the possible antagonistic effect of the AEDS on PTZ-and DMCMinduced reduction of GABA responses was determined.
The convulsant drugs PTZ and DMCM reduced GABA responses in a concentration-dependent manner, consistent with previous observations (Pellmar and Wilson, 1977; Macdonald and Barker, 1978~; Jensen and Lambert, 1983; Skerritt and Macdonald, 1984) . This reduction of postsynaptic GABAergic inhibition might underlie the convulsant activity of these drugs. Our results also confirm that DMCM exerts its effect on GABA responses through an interaction with the benzodiazepine receptor. Indeed, the benzodiazepine receptor antagonists CGS 9896 and ZK 91296 (De Deyn and Macdonald, 1987) completely antagonized the DMCM effect. DMCM is an inverse agonist at the benzodiazepine receptor (Jensen and Lambert, 1983; Skerritt and Macdonald, 1984) , which probably explains the protective activity of ZK 912% against DMCM-induced seizures (Klockgether et al., 1985) . PTZ, however, was previously demonstrated to inhibit GABA responses through an interaction with a different site on the GABA receptor, possibly the picrotoxin receptor Barker, 1977, 1978~) .
The anticonvulsants ESM, DMO, and VPA ap- Harrison and Simmonds, 1982) . The observed concentration-dependent effect of DZP on GABA responses with a maximal direct effect of 82.4% is consistent with previous findings (Choi et al., 1977; Macdonald and Barker, 19786; Skemtt et al., 1984) . The two experimental AEDs CGS 9896 and ZK 91296, however, applied at a concentration of 2 pM remained inactive in this paradigm. This finding is consistent with previous work describing CGS 98% and ZK 91296 to be pure antagonists at the benzodiazepine receptor (De Deyn and Macdonald, 1987) .
With the exception of DZP, none of the tested AEDs antagonized or reversed PTZ-induced inhibition of GABA responses. The applied PTZ concentration (1 mM) was comparable to the critical brain PTZ level for onset of seizures in mice (Yonekawa et al., 1980) . Behavioral studies, however, demonstrated the protective action of VPA, DMO, ESM, CGS 98%, and ZK 91296 against PTZ-induced seizures (Chen et al., 1963;  Krall et al., 1978; Petrack et al., 1983; Petersen et al., 1984) . DZP (100 nM) coapplied with PTZ (1 mM) reversed the inhibition of GABA responses. This is consistent with behavioral findings for this benzodiazepine receptor agonist (Haefely et al., 1981) .
Neither VPA, DMO, nor ESM antagonized DMCM-induced reduction of GABA responses. DZP, however, antagonized the DMCM-induced inhibition of GABA responses. This is probably due to its high-affinity binding at the benzodiazepine receptor in competition with DMCM (Haefely et al., 1981) . CGS 98% and ZK 91296, although devoid of any intrinsic effect, completely antagonized the DMCM-induced reduction of GABA responses. This is explained by the previously demonstrated antagonistic effect of these compounds at the benzodiazepine receptor (De Deyn and Macdonald, 1987) . The demonstrated antagonism of the DMCM effect might be the underlying mechanism for the protective action against DMCM-induced seizures for ZK 91296 (Klockgether et al., 1985) .
The lack of effects of VPA, ESM, and DMO on postsynaptic GABA action contrasts with their clinical efficacy against generalized absence seizures, and suggests that direct postsynaptic enhancement of GABAergic inhibition is not a common mechanism of action of antiabsence AEDs. These results also suggest that the disturbance responsible for generalized absence seizures may not be localized to the GABA receptor. Alternatively, the therapeutic efficacy of these AEDs may be due to the stimulation of GABA synthesis andor the inhibition of GABA metabolism as has been shown for VPA (Volzke and Doose, 1973;  Hammond and Wilder, 1985) . Finally, there may be alterations in pathologic neurons, and their interactions may not have been present in our neurons in culture.
Our results suggest that DZP most probably exerts its antiabsence effect by enhancing GABAmediated inhibition through an interaction with the benzodiazepine receptor. CGS 98% and ZK 912%, two experimentally proved AEDs, were shown to be pure antagonists at the benzodiazepine receptor. Their anticonvulsant effect against DMCM-induced seizures can be explained by their benzodiazepine receptor antagonistic effect. Their mechanism against PTZ-induced seizures is less clear. The existence of an endogenous benzodiazepine receptor inverse agonist has been proposed (Guidotti et al., 1982 
RESUMEN
Los mecanismos de acci6n de las medicaciones antiepiltpticas eficaces contra 10s ataques generalizados de ausencia (AEDs antiausencia) permanecen inciertos. Los AEDs antiausencia son, generalmente, eficaces contra ataques experimentales inducidos por el pentilentetrazol (PTZ) y el metil-6,7-dimetoxy-4-etilpcarbolina-3-carboxilato (DMCM) en animales, medicaciones que reducen la inhibicibn GABAfrgica. Hemos estudiado 10s efectos de varios AEDs sobre respuestas-GABA registradas en las neuronas de la mfdula espinal de ratones que habian crecido en cultivos de celulas primarieas disociadas. Cuatro AEDs antiausencia fueron incluidos: etoxusimida (ESM), dimetadiona (DMO), valproato s6dico (VPA) y diazepan (DZP). Tambitn se incluyeron dos AEDs experimentales, CGS 98% y ZK 912%, con acci6n anticonvulsiva contra 10s ataques inducidos por PTZ o DMCM. Tambifn se valoraron 10s posibles efectos de 10s
AEDs antiausencia y experimentales sobre el PTZ y la inhibici6n de las respuestas-GABA inducidas por el DMCM. El PTZ y el DMCM redujeron las respuestas-GABA de modo reversible y dependiendo de sus concentraciones. El PTZ inhibi6 cmpletamente las respuestas-GABA a 10 mM (ICs0 de 1.1 mM) mientras que la inhibici6n de las respuestas GABA inducida por el DMCM alcanz6 un nivel estable del39% de 10s valores control con I pM (lC50 de 33 mM). La ESM (1200 pM), la DMO (6 mM), el VPA (200 pM), el CGS 98% (2 pM) y el ZK 98% (2 pM) no alteraron las respuestas-GABA. El DZP aument6 las respuestas GABA de una manera concentraci6n-dependiente. La inhibici6n de las respuestas-GABA producidas por el PTZ (1 mM), no se alter6 con las ESM (600 pM), la DMO (6 mM), el CGS 98% (1 pW o el ZK 98% (1 pM). La co-aplicacion de VPA (200 pM) y el PTZ (1 mM) aument6 ligeramente 10s efectos del PTZ. Sin embargo el DZP (>lo nM) revirti6 la reducci6n de las respuestas GABA inducidas por el PTZ. La reducci6n de las respuestas GABA producida por el DMCM (250 nM) no fue alterada por la ESM (600 pM), la DMO (2 mM) o el VPA (200 m. Sin embargo el CGS 98% (2 pM), y el ZK 912% (2 pM), antagonizaron el efecto del DMCM. El DZP (>I0 nM) revirti6 significativamente la inhibici6n de las respuestas GABA inducidas por el DMCM. La falta de efectos de CPA, ESM y DMO sobre las respuestas GABA post-sinlpticas sugiere que el incremento de la acci6n GABA post-sinlptica no es un mecanismo comdn de actuaci6n de las AEDs antiausencia. Todas las AEDs DZP, CGS 98% y ZK 912% revirtieron la reducci6n de las respuestas GABA producidas por el DMCM per0 no las inducidas por el PTZ lo que sugiere que estos AEDs bloquean 10s ataques DMCM actuando sobre 10s receptores de la benzodiazepina. Sin embargo, puesto que el incremento de las respuestas GABA s6lo se produce por el DZP, permanece todavia sin aclarar el por q u t el CGS 98% y el ZK 912% bloquean 10s ataques producidos por el PTZ.
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